Federica Castri

Federica Castri

Auto-generated profile, based on publicly available information

Federica Castri

UOC di Anatomia Patologica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Pancreas
Verified
Journal Article
Closed access
SMSergio Morini
Sergio Morini
Giuseppe PerroneGiuseppe Perrone
Giuseppe Perrone
DBDomenico Borzomati
Domenico Borzomati
BVBruno Vincenzi
Bruno Vincenzi
CRCarla Rabitti
Carla Rabitti
AMAndrea Onetti Muda
Andrea Onetti Muda
The objective of the study was to verify if histopathological differentiation of ampullary carcinoma after surgical resection may be related to survival. The prognostic role of an accurate histological and immunohistochemical classification has been investigated in a multicentric series of carcinoma of the ampulla of Vater. Immunohistochemical expression of cytokeratin 7 (CK7) and CK20 were analyzed in the different morphological histotypes of ampullary cancers, and results were compared with overall survival. Of 72 ampullary cancers, 48.6% were classified as pancreaticobiliary-type carcinomas, 43.1% were classified as intestinal-type carcinomas, and 8.3% were classified as “unusual”-type carcinomas. Cytokeratin 20 was expressed in 28 (90.3%) of the 31 intestinal-type carcinomas, whereas it was always negative in the pancreaticobiliary histotype; CK7 was expressed in 32 (91.4%) of the 35 pancreaticobiliary-type carcinomas and in 18 (58.1%) of the 31 intestinal-type carcinomas. By univariate analysis, overall survival was influenced significantly by pathological T factor, lymph node involvement, and histological/immunohistochemical subtyping. Furthermore, using a multivariate Cox regression model, lymph node metastasis and CK20 were identified as significant independent factors related to prognosis. Our results prove the clinical use of ampullary cancer subclassification based on different histotypes and indicate the useful role of the CK7/CK20 expression profile for consistent histopathological classification and prognostic relevance.

19 September 2005 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
PMPaolo Magistrelli
Paolo Magistrelli
RCRoberto Coppola
Roberto Coppola
GTGiuseppe Tonini
Giuseppe Tonini
BVBruno Vincenzi
Bruno Vincenzi
SDSantini Daniele
Santini Daniele
APAurelio Picciocchi
Aurelio Picciocchi

17 August 2018 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
RRRiccardo Ricci
Riccardo Ricci
MGMaria Cristina Giustiniani
Maria Cristina Giustiniani
MGMarco Gessi
Marco Gessi
PLPaola Lanza
Paola Lanza
FCFederica Castri
Federica Castri
MRMauro Risio
Mauro Risio
PDGFRA mutations in the gastrointestinal (GI) tract can cause GI stromal tumour (GIST) and inflammatory fibroid polyp (IFP). Hitherto no cell type has been identified as a physiological counterpart of the latter, while interstitial Cajal cells (ICC) are considered the precursor of the former. However, ICC hyperplasia (ICCH), which strongly supports the ICC role in GIST pathogenesis, has been identified in germline KIT‐mutant settings but not in PDGFRA‐mutant ones, challenging the precursor role of ICC for PDGFRA‐driven GISTs. Telocytes are a recently described interstitial cell type, CD34+/PDGFRA+. Formerly considered fibroblasts, they are found in many organs, including the GI tract where they are thought to be involved in neurotransmission. Alongside IFPs and gastric GISTs, GI wall “fibrosis” has been reported in germline PDGFRA‐mutants. Taking the opportunity offered by its presence in a germline PDGFRA‐mutant individual, we demonstrate that this lesion is sustained by hyperplastic telocytes, constituting the PDGFRA‐mutant counterpart of germline KIT mutation‐associated ICCH. Moreover, our findings support a pathogenetic relationship between telocyte hyperplasia and both IFPs and PDGFRA‐mutant GISTs. We propose the term “telocytoma” for defining IFP, as it conveys both the pathogenetic (neoplastic) and histotypic (“telocytary”) essence of this tumour, unlike IFP, which rather evokes an inflammatory‐hyperplastic lesion.

1 January 2010 in Pathology - Research and Practice
Verified
Journal Article
Closed access
ACAntonella Coli
Antonella Coli
AGAndrea Di Giorgio
Andrea Di Giorgio
FCFederica Castri
Federica Castri
CDCarmelo Destito
Carmelo Destito
AMAlfredo Wiel Marin
Alfredo Wiel Marin
GBGiulio Bigotti
Giulio Bigotti

9 July 2019 in Histopathology
Verified
Journal Article
Closed access
PDF file
FCFederica Castri
Federica Castri
Gloria RavegniniGloria Ravegnini
Gloria Ravegnini
CLClaudio Lodoli
Claudio Lodoli
Vincenzo FiorentinoVincenzo Fiorentino
Vincenzo Fiorentino
CACarlo Abatini
Carlo Abatini
RRRiccardo Ricci
Riccardo Ricci

1 October 2020 in Digestive and Liver Disease
Verified
Journal Article
Closed access
DPDaniela Pugliese
Daniela Pugliese
AAAlessandro Armuzzi
Alessandro Armuzzi
FCFederica Castri
Federica Castri
RBRoberta Benvenuto
Roberta Benvenuto
AMAntonella Mangoni
Antonella Mangoni
VTValentina Trapani
Valentina Trapani